At a glance
ClinicalIndex Comparison RecordN/ACompleted· 95 enrolled
Drug / intervention
SMS reminder +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment if a Daily SMS (Short Message System) Reminder Improves the Adherence of COPD Patients to Therapy With Spiriva® 18 Microgram
In Brief
An observational study evaluating SMS reminder and control group for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 95 participants across 5 sites.
Detailed Summary
6 months open label non-interventional observational study acc to § 4, section 23 and § 67, section 6 German Medicines Act with two parallel groups 1. the SMS group receiving a daily SMS - a reminder to inhale Spiriva® 18 Microgram 2. the control group not receiving a daily SMS reminder
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2011
First PostedMar 2011
Primary CompletionNov 2011
TodayJul 2026
First PostedMar 4, 2011
Enrollment StartMar 1, 2011
Primary CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 15.3 years ago
Interventions
SMS reminderprocedure
daily SMS in the SMS group to remind of treatment with tiotropium
control groupprocedure
no daily SMS to remind of treatment with tiotropium